GHAM
Gilman Hill Asset Management’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,950
| Closed | -$319K | – | 183 |
|
|
2018
Q1 | $319K | Sell |
3,950
-2,300
| -37% | -$186K | 0.14% | 128 |
|
|
2017
Q4 | $525K | Hold |
6,250
| – | – | 0.21% | 106 |
|
|
2017
Q3 | $537K | Sell |
6,250
-75
| -1% | -$6.44K | 0.22% | 104 |
|
|
2017
Q2 | $528K | Hold |
6,325
| – | – | 0.23% | 101 |
|
|
2017
Q1 | $470K | Sell |
6,325
-2,227
| -26% | -$165K | 0.2% | 108 |
|
|
2016
Q4 | $623K | Buy |
8,552
+410
| +5% | +$29.9K | 0.23% | 84 |
|
|
2016
Q3 | $643K | Buy |
8,142
+90
| +1% | +$7.11K | 0.25% | 77 |
|
|
2016
Q2 | $664K | Hold |
8,052
| – | – | 0.27% | 71 |
|
|
2016
Q1 | $583K | Buy |
8,052
+600
| +8% | +$43.4K | 0.27% | 73 |
|
|
2015
Q4 | $641K | Sell |
7,452
-58
| -0.8% | -$4.99K | 0.31% | 68 |
|
|
2015
Q3 | $690K | Buy |
7,510
+177
| +2% | +$16.3K | 0.36% | 61 |
|
|
2015
Q2 | $721K | Sell |
7,333
-100
| -1% | -$9.83K | 0.34% | 67 |
|
|
2015
Q1 | $733K | Sell |
7,433
-50
| -0.7% | -$4.93K | 0.35% | 66 |
|
|
2014
Q4 | $693K | Buy |
7,483
+108
| +1% | +$10K | 0.35% | 63 |
|
|
2014
Q3 | $694K | Hold |
7,375
| – | – | 0.38% | 62 |
|
|
2014
Q2 | $668K | Sell |
7,375
-75
| -1% | -$6.79K | 0.35% | 62 |
|
|
2014
Q1 | $633K | Buy |
7,450
+2,500
| +51% | +$212K | 0.37% | 59 |
|
|
2013
Q4 | $398K | Buy |
4,950
+200
| +4% | +$16.1K | 0.26% | 70 |
|
|
2013
Q3 | $364K | Sell |
4,750
-1,500
| -24% | -$115K | 0.26% | 65 |
|
|
2013
Q2 | $442K | Buy |
+6,250
| New | +$442K | 0.32% | 64 |
|